NIH-funded research Fellowship grant

Understanding how immune cells recognize insulin in type 1 diabetes

Official title: Evolution of B Lymphocyte Insulin Autoantigen Recognition in Type 1 Diabetes

Funded at Vanderbilt University · NIH-10997967 · Data updated 2026-11-12

This study is looking at how certain immune cells called B lymphocytes interact with insulin in type 1 diabetes, using mice to understand how these interactions change over time, which could help develop better treatments for people with diabetes.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionVanderbilt University
NIH-funded
Lab location1 site (Nashville, UNITED STATES)
Project startSeptember 1, 2024
Project endAugust 31, 2027
Funding year2024
Award (this year)$34,295
NIH project number1F31DK141224-01
Project IDNIH-10997967 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at risk of developing type 1 diabetes or those recently diagnosed with the condition.

Less likely to help

Patients with type 1 diabetes who are not at risk or have advanced stages of the disease may not benefit from this research.

What this research studies

This research investigates the role of B lymphocytes in type 1 diabetes (T1D) by examining how these immune cells recognize insulin and present it to other immune cells. The study uses a mouse model to explore the evolution of insulin-binding B lymphocytes and their impact on the progression of T1D. By analyzing the changes in B cell receptor (BCR) recognition of insulin over time, the research aims to identify factors that contribute to the heterogeneity of diabetes onset and response to immunotherapy. This knowledge could lead to improved immunotherapy strategies for T1D patients.

Why it matters

Potential benefit: If successful, this research could lead to more effective immunotherapies for type 1 diabetes, improving patient outcomes.

How similar studies have gone: Previous research has shown promise in understanding immune responses in type 1 diabetes, but this specific approach to studying B lymphocyte evolution is relatively novel.

Where this research is happening

  • Vanderbilt University
    Nashville, United States
    Active

Researchers

  • Principal investigator: Bass, Lindsay Emma — Vanderbilt University
  • Study coordinator: Bass, Lindsay Emma

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.